Medical Weight Loss for Denver, Colorado Residents

Denver, Colorado residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Denver through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Wondering if you qualify in Denver? Eligibility for compounded GLP-1 care is confirmed by Dr. Sharma during your video visit, based on your health history, not your zip code in Colorado. Doctor review just $119 (medication separate).

Why Denver Residents Choose New Hope Weight Loss

For Denver patients who want a doctor genuinely involved, this is the right fit. Compounded semaglutide and tirzepatide are powerful tools, but they are not for everyone, and Dr. Anjmun Sharma treats them that way. She looks at your labs, your medications, and your goals before anything is prescribed, then keeps adjusting as your body responds. These medications are not FDA-approved and results vary, which is exactly why physician oversight matters this much.

Denver is served through telehealth from our Costa Mesa, California clinic. The consultation, prescription, and follow-ups all happen by secure video, no travel required.

Think of our Costa Mesa clinic as your weight-loss provider even though you live in Denver, because telehealth delivers the same physician-led program to Colorado without asking you to leave home. We care for patients throughout Downtown, LoDo, Capitol Hill, Cherry Creek, Wash Park, and the greater Front Range. Every prescription is reviewed and authorized by Dr. Anjmun Sharma, MD, before anything is sent to your address in Colorado.

A patient in the busiest part of Denver and one in a quiet Colorado suburb pay exactly the same: $119 for the physician review and semaglutide from $166 per month. If you and Dr. Sharma decide tirzepatide fits your goals, Denver patients can begin from $233 per month, billed apart from your initial $119 visit. Across the cities and mountain towns of Colorado, New Hope Weight Loss treats patients entirely by telehealth from our Costa Mesa, California clinic, so the same physician care reaches you wherever you are.

GLP-1 Weight Loss Programs Available

Begin your reset: semaglutide, from $166/mo

The 90-Day Metabolic Reset gives Denver patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.

Go further: tirzepatide, from $233/mo

Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.

Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Denver

Telehealth means your weight-loss care travels to you instead of the other way around. Patients across Denver and the rest of start with a detailed online quiz covering medical history and goals. Dr. Anjmun Sharma personally reviews each intake and connects by secure video, usually inside 48 hours, to decide together whether a compounded GLP-1 is right. When she writes a prescription, the medication is filled by a state-licensed 503(a) pharmacy and mailed to your Denver door in temperature-controlled cold-pack packaging. Ongoing follow-ups also happen by video, keeping your plan on track without a single in-person appointment.

Frequently Asked Questions, Denver

Is there somewhere in Denver I can visit New Hope Weight Loss?

There is no physical office in Denver. We work from a single clinic in Costa Mesa, California, and care for Denver, Colorado patients by telehealth. Your candidacy for a compounded GLP-1 plan is confirmed when Dr. Anjmun Sharma reviews your health information during an online video appointment.

Will Denver patients have to make any in-person trips?

No trips are necessary. We provide care to Denver completely through telehealth, covering consults, follow-up visits, and ongoing support remotely. Once Dr. Sharma signs off, your compounded semaglutide or tirzepatide is delivered to Denver in cold-pack shipping that preserves the correct temperature.

What does the program cost a Denver patient?

Budget $119 for the physician visit. Semaglutide is priced from $166 monthly or $499 for 90 days, and tirzepatide from $233 monthly. The medication is a separate line item. We accept HSA, FSA, Klarna, and Affirm, and no distance surcharge is added for patients located in Denver.

What areas of Denver do you serve?

We serve patients from across Denver by telehealth, including Downtown, LoDo, Capitol Hill, Cherry Creek, Wash Park, and the greater Front Range.

Is California telehealth treatment legitimate for Denver patients?

Yes. Dr. Anjmun Sharma is a licensed physician, and telehealth is an established, regulated way to deliver care. Denver patients get a real physician consultation, contraindication screening, and a named 503(a) compounding pharmacy. Telehealth eligibility is confirmed at the consultation.

Denver Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Denver, Colorado by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.